Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 26;5(5):e00127.
doi: 10.1042/AN20130033.

MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis

Affiliations

MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis

Carine Savarin et al. ASN Neuro. .

Abstract

Infection of the CNS (central nervous system) with a sublethal neurotropic coronavirus (JHMV) induces a vigorous inflammatory response. CD4⁺ and CD8⁺ T cells are essential to control infectious virus but at the cost of tissue damage. An enigma in understanding the contribution of T cell subsets in pathogenesis resides in their distinct migration pattern across the BBB (blood brain barrier). CD4⁺ T cells transiently accumulate within the perivascular space, whereas CD8⁺ T cells migrate directly into the CNS parenchyma. As MMPs (matrix metalloproteinases) facilitate migration across the glia limitans, specific expression of the TIMP (tissue inhibitor of MMPs)-1 by CD4⁺ T cells present in the perivascular cuffs suggested that TIMP-1 is responsible for stalling CD4⁺ T cell migration into the CNS parenchyma. Using TIMP-1 deficient mice, the present data demonstrate an increase rather than a decrease in CD4⁺ T cell accumulation within the perivascular space during JHMV infection. Whereas virus control was not affected by perivascular retention of CD4⁺ T cells, disease severity was decreased and associated with reduced IFNγ (interferon γ) production. Moreover, decreased CD4⁺ T cell recruitment into the CNS parenchyma of TIMP-1 deficient mice was not associated with impaired T cell recruiting chemokines or MMP expression, and no compensation by other TIMP molecules was identified. These data suggest an MMP-independent role of TIMP-1 in regulating CD4⁺ T cell access into the CNS parenchyma during acute JHMV encephalitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Disease severity is decreased in TIMP-1−/− compared to WT mice, despite similar virus clearance and extent of demyelination
(A) Clinical symptoms were monitored daily in WT and TIMP-1−/− mice. Data represent the mean of seven experiments with 15–20 mice per experiment, **P<0.01 and ***P<0.001. (B) Virus replication in brains of WT and TIMP-1−/− mice analyzed by plaque assay. Data represent the average±S.E.M. of six individual mice per group per time point combined from two experiments. (C) Percentage of demyelination in spinal cord white matter of WT and TIMP-1−/− mice between days 7 and 14 p.i. Data represent the mean±S.E.M. of at least three mice per group per time point. (D) IFNγ mRNA expression analyzed by real-time PCR in naïve, JHMV infected WT and TIMP-1−/− mice. Data represent the mean±S.E.M. of three individuals per group per time point.
Figure 2
Figure 2. TIMP-1 deficiency does not alter CNS inflammation
Numbers of total inflammatory leukocytes (CD45hi), neutrophils (ly6G+), monocytes (F4/80+), CD8+ and CD4+ T cells per brain in WT and TIMP-1−/− infected mice. Data represent the mean±S.E.M. of 12 mice per group per time point combined from four separate experiments (n=3 per time point and group per experiment).
Figure 3
Figure 3. CD4+ T cells are retained in the perivascular space of TIMP-1−/− mice
(A) CD4+ T cell perivascular cuffs in WT and TIMP-1−/− mice at day 7 p.i. analyzed by immunofluorescent microscopy. The two basement membranes of the BBB stained with laminin (red), delimit the perivascular space. CD4+ T cells appear in green. Scale bar, 25 μm. (B) Total number of CD4+ T cells and their distribution in the perivascular space versus parenchyma analyzed in WT and TIMP-1−/− mice at day 7 and 10 p.i. Data represent the mean±S.E.M. of six mice per group combined from two separate experiments (with n=3 for each individual experiment).
Figure 4
Figure 4. Chemokine expression in infected WT and TIMP-1−/− mice
CCL5 and CXCL10 mRNA, measured by real-time PCR, and protein, measured by ELISA, in naïve or infected WT and TIMP-1−/− mice. Data represent the mean±S.E.M. of three to seven individual mice per group per time point.
Figure 5
Figure 5. TIMPs and MMPs do not compensate for TIMP-1 deficiency during JHMV infection
Expression of TIMP-1, -2, -3 and -4 mRNA (A), and MMP-3 and -12 mRNA (B), analyzed by real-time PCR in naïve and JHMV infected WT and TIMP-1−/− mice. Transcript levels depict the average±S.E.M. of three individual brains per group per time point representative of two separate experiments. (C) MMP9 activity determined by zymography of CNS mononuclear cells isolated from infected WT and TIMP-1−/− mice at days 3 and 7 p.i. Data are representative of two experiments.

Similar articles

Cited by

References

    1. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med. 2006;203:1007–1019. - PMC - PubMed
    1. Agrawal SM, Silva C, Wang J, Tong JP, Yong VW. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis. J Neuroinflammation. 2012;9:64. - PMC - PubMed
    1. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci. 2011;14:1142–1149. - PubMed
    1. Althoff GE, Wolfer DP, Timmesfeld N, Kanzler B, Schrewe H, Pagenstecher A. Long-term expression of tissue-inhibitor of matrix metalloproteinase-1 in the murine central nervous system does not alter the morphological and behavioral phenotype but alleviates the course of experimental allergic encephalomyelitis. Am J Pathol. 2010;177:840–853. - PMC - PubMed
    1. Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol. 2007;28:5–11. - PubMed

Publication types

MeSH terms

LinkOut - more resources